How Teladoc is teeing itself up to dominate telehealth after Covid-19
Teladoc is teeing itself up to remain a dominant digital health provider long after the worst of the pandemic subsides.
Teladoc is teeing itself up to remain a dominant digital health provider long after the worst of the pandemic subsides.
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
In a rare observed case of self-treatment in a wild animal, scientists documented an orangutan applying a medicinal plant to a wound on his face.
The company belatedly conceded both that it had paid the cybercriminals extorting it and that patient data nonetheless ended up on the dark web.
The DEA is allowing annual and semi-annual production quotas for Schedule II drugs, after it became clear quarterly quotas would worsen shortages.
Three years ago, Moderna invested part of its vaccine windfall into a new gene-editing startup, Metagenomi. Now it’s backing out.
Over the last decade, private equity firms acquired scores of wheelchair makers. Now, users routinely wait months to get their chairs repaired.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A STAT Investigation: Brain biopsies on “vulnerable” patients at Mount Sinai set off alarm bells at FDA, documents show.
A House subcommittee investigating the “lab leak” theory of Covid origins accuses EcoHealth of misrepresenting its virus research in Wuhan and pushes to deny it…
An experimental gene therapy seems to alleviate skeletal defects tied to rare inherited disease, a new study shows.